Each 150 mg SUNOSI film-coated tablet contains 150 mg solriamfetol (equivalent to 178.5 mg solriamfetol hydrochloride). Each 75 mg SUNOSI film-coated tablet contains 75 mg solriamfetol (equivalent to 89.3 mg solriamfetol hydrochloride). SUNOSI tablets are intended for oral administration. Solriamfetol hydrochloride is a white to off-white solid that is freely soluble in water. The molecular formula is C 10H 15N 2O 2Cl, and the molecular weight is 230.69. Solriamfetol is a phenylalanine derivative with the systematic name ( R)-2amino-3-phenylpropylcarbamate hydrochloride. SUNOSI contains solriamfetol, a dopamine and norepinephrine reuptake inhibitor (DNRI). You may report side effects to FDA at 1-80. For more information, ask your doctor or pharmacist.Ĭall your doctor for medical advice about side effects. These are not all the possible side effects of Sunosi. Tell the doctor if you have any side effect that bothers you or that does not go away. The most common side effects of Sunosi include: Get medical help right away, if you have any of the symptoms listed above.
Sunosi belongs to a class of drugs called Dopamine/Norepinephrine Reuptake Inhibitors. Sunosi may be used alone or with other medications. Sunosi is a prescription medicine used to treat the symptoms of Narcolepsy and Obstructive Sleep Apnea.
0 kommentar(er)
